Some cancer treatments can affect the heart. Cardio-oncology is the part of cardiology that manages that overlap: assessing heart risk before therapy starts, watching for early warning signs during treatment, and looking after the heart in the years that follow. The aim is almost never to stop cancer treatment. It is to make the treatment plan safely possible.
When a cardiology review helps
Heart history, examination, ECG, and echocardiography before therapy that can affect the heart, with blood pressure, diabetes, and cholesterol brought under control early.
Scheduled echo reviews during higher-risk therapy, and prompt assessment of new breathlessness, chest discomfort, palpitations, swelling, or falling effort tolerance.
Review of heart function once therapy ends, and a clear plan for how long cardiac follow-up should continue based on the treatment received.
Some effects appear years later, particularly after radiotherapy near the heart or higher cumulative chemotherapy doses. New symptoms in a survivor deserve a low threshold for review.
Treatments that can involve the heart
The risk is specific to the treatment and to the patient. Anthracycline chemotherapy, HER2-targeted therapy, some newer targeted and immune therapies, and radiotherapy fields near the heart are the common reasons an oncology team asks for cardiac review. Dose, drug combinations, age, and existing heart disease all change the picture, which is why the assessment is individual rather than a checklist.
Heart disease that already exists at the time of a cancer diagnosis matters just as much. A patient with prior stenting, weak heart function, or valve disease may need their cardiac plan adjusted so that surgery, chemotherapy, or radiotherapy can proceed on schedule.
What a consultation involves
The visit brings the cancer story and the heart story together: the treatment plan or treatment history, symptoms, examination, ECG, and echocardiography, with transesophageal or contrast echo, stress testing, Holter, or ambulatory blood pressure monitoring when they genuinely add information. It ends with a written opinion the oncology team can act on: fit to proceed, proceed with protection and monitoring, or treat the heart first.
Working with the oncology team
Five years at a dedicated cancer hospital shape how this clinic works. Decisions are made with the treating oncologist, not around them, reports go back in language that supports the treatment timeline, and interrupting cancer therapy is treated as a last resort rather than a reflex.